170 related articles for article (PubMed ID: 37666979)
1. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus.
Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Kumar GS; Dubey A; Dwivedi VD; Azhar EI
Sci Rep; 2023 Sep; 13(1):14570. PubMed ID: 37666979
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
[TBL] [Abstract][Full Text] [Related]
4. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
5. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.
Wang J
J Chem Inf Model; 2020 Jun; 60(6):3277-3286. PubMed ID: 32315171
[TBL] [Abstract][Full Text] [Related]
6. Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico.
Abduljalil JM; Elfiky AA; Elgohary AM
J Infect Public Health; 2023 Jul; 16(7):996-1003. PubMed ID: 37167647
[TBL] [Abstract][Full Text] [Related]
7. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
8. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
[TBL] [Abstract][Full Text] [Related]
9. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
[TBL] [Abstract][Full Text] [Related]
10.
Lokhande KB; Shrivastava A; Singh A
J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
[TBL] [Abstract][Full Text] [Related]
11. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
12. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease.
Bhattacharjee A; Ahammad I; Chowdhury ZM; Das KC; Keya CA; Salimullah M
Mol Biotechnol; 2024 Apr; 66(4):626-640. PubMed ID: 36357534
[TBL] [Abstract][Full Text] [Related]
13. Vaccinomics to design a multi-epitope-based vaccine against monkeypox virus using surface-associated proteins.
Khan S; Irfan M; Hameed AR; Ullah A; Abideen SA; Ahmad S; Haq MU; El Bakri Y; Al-Harbi AI; Ali M; Haleem A
J Biomol Struct Dyn; 2023 Dec; 41(20):10859-10868. PubMed ID: 36533379
[TBL] [Abstract][Full Text] [Related]
14. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
Khan RJ; Jha RK; Amera GM; Jain M; Singh E; Pathak A; Singh RP; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2021 May; 39(8):2679-2692. PubMed ID: 32266873
[TBL] [Abstract][Full Text] [Related]
15. Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective.
Abduljalil JM; Elfiky AA
J Infect; 2022 Dec; 85(6):702-769. PubMed ID: 36089103
[No Abstract] [Full Text] [Related]
16. Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase.
Rabaan AA; Alwashmi ASS; Mashraqi MM; Alshehri AA; Alawfi A; Alshengeti A; Najim MA; AlShehail BM; AlShahrani AJ; Garout M
Mol Divers; 2023 Aug; ():. PubMed ID: 37531040
[TBL] [Abstract][Full Text] [Related]
17. Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study.
Rabaan AA; Alshahrani FS; Garout M; Alissa M; Mashraqi MM; Alshehri AA; Alsaleh AA; Alwarthan S; Sabour AA; Alfaraj AH; AlShehail BM; Alotaibi N; Abduljabbar WA; Aljeldah M; Alestad JH
Mol Divers; 2024 Apr; ():. PubMed ID: 38652365
[TBL] [Abstract][Full Text] [Related]
18. Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?
Dodaro A; Pavan M; Moro S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108279
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease.
Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Eltaib L; Alshehri A; Alsaiari AA; Kamal M; Alshammari AMA
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509664
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics.
Alagarsamy V; Shyam Sundar P; Raja Solomon V; Narendhar B; Sulthana MT; Rohitha K; Dhanwar S; Dharshini Aishwarya A; Murugesan S
J Biomol Struct Dyn; 2023 Dec; 41(20):10678-10689. PubMed ID: 36905675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
